Perceived health status of women with overt and subclinical hypothyroidism

Medical Principles and Practice

Volumn 18, Issue 4, 2009, Pages 317-322

  Vigário, Patrícia ^a,b   Teixeira, Patrícia ^a   Reuters, Vaneska ^a   Almeida, Cloyra ^a   Maia, Maicon ^a   Silva, Marina ^a   Vaisman, Mário ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Federal University of Rio de Janeiro ^*  (Brazil)

Author keywords

Health status; Hypothyroidism; Quality of life; SF 36

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HEALTH STATUS; HUMAN; HYPOTHYROIDISM; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; PAIN; PATIENT SATISFACTION; RANK SUM TEST; SHORT FORM 36; THYROTROPIN BLOOD LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; HYPOTHYROIDISM; INTERPERSONAL RELATIONS; MENTAL HEALTH; MIDDLE AGED; PAIN; QUALITY OF LIFE; WOMEN'S HEALTH;

EID: 67650240618     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215731     Document Type: Article

References (31)

1. Osman F, Gammage MD, Franklyn JA: Thyroid disease and its treatment: short-term and long-term cardiovascular consequences. Curr Opin Pharmacol 2001; 6:626-631.
2. Franklyn JA: Hypothyroidism. Medicine 2005; 33: 27-29.
3. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A: The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005; 165: 1714 -1720.
4. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM: Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005; 90: 2666-2674.
5. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC: Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 2006; 119:541-551.
6. Rodondi N, Newman AB, Vittinghoff E, Rekeneire N, Satterfield S, Harris TB, Bauer DC: Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005; 165:2460-2466.
7. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K: Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J 2005; 52:89-94.
8. Fleck MPA, Leal OF, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, Pinzon V: Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida 'WHOQOL-Bref'. Rev Sau Publ 2000; 34:178-183.
9. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ: Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997; 82: 771-776.
10. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR: Brazilian-Portuguese version of the SF-36: a reliable and valid quality of life outcome measure. Rev Bras Reumatol 1999; 39: 143-150.
11. Cortina JM: What is Coefficient Alpha? An examination of theory and applications. J Appl Physiol 1993; 78: 98-104.
12. Altman DG: Practical Statistics for Medical Research. London, Chapman and Hill, 1991.
13. Minayo MCS, Hartz ZMA, Buss PM: Qualidade de vida e saúde: um debate necessário. Cien Saud Colet 2000; 5: 7-18 .
14. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU: The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007; 92:1715-1723.
15. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B: Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 2006; 37: 133-139.
16. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F,Cerutti R, Zoli M, Marchesini G: Health related quality of life in patients with thyroid disorders. Qual Life Res 2004; 13:45-54.
17. Banegas JR, Guallar-Castillon P, Rodriguez-Artalejo F, Graciani A, Lopez-Garcia E, Ruilope LM: Association between awareness, treatment, and control of hypertension, and quality of life among older adults in Spain. Am J Hypertens 2006; 19:686-693.
18. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Herreros-Fernandez V: Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens 2003; 21:1283-1289.
19. Sprangers MA, Regt EB, Andries F, Agt HM, Bijl RV, Boer JB, Foets M, Hoeymans N, Jacobs AE, Kempen GI, Miedema HS, Tijhuis MA, Haes HC: Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 2000; 53:895-907.
20. Watt T, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedus L, Bjorner JB, Feldt-Rasmussen U: Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 2006; 154: 501-510.
21. Reuters VS, Teixeira PFS, Castro CLN, Almeida CP, Cardoso HR, Porciuncula IM, Nobre THS, Reis FAA, Buescu A, Vaisman M: Skeletal muscle dysfunction in patients with subclinical hypothyroidism. Acta Fisiat 2003; 10:7-11.
22. Gonen MS, Kisakol G, Cilli AS, Dikbas O, Gungor K, Inal A, Kaya A: Assessment of anxiety in sublinical thyroid disorders. Endocr J 2004; 51: 311- 31 5 .
23. Gerding, MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM: Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997; 7:885-889.
24. Ljunggren JG, Torring O, Wallin G, Taube A, Tallstedt L, Hamberger B, Lundell G: Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 1998; 8: 653-659.
25. Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W, Gorges R: Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 2006; 15: 695-703.
26. Thompson B: 'Statistical', 'practical', and 'clinical': how many kinds of significance do counselors need to consider? J Couns Develop 2002; 80: 64-71.
27. Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR: Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease: a community-based study. Clin Endocrinol (Oxf) 2007; 66:548-556.
28. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM: Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002; 57:577-585.
29. Walsh JP: Dissatisfaction with thyroxine therapy: could the patients be right? Curr Opin Pharmacol 2002; 2: 717-722.
30. Fleck MPA, Leal OF, Louzada S, Xavier M, Cha c ha mov ich E , Vie i ra G, Sa ntos L , P i n z on V: Desenvolvimento da versão em português do instrumento de avaliação de qualidade de vida da OMS (WHOQOL-100). Rev Bras Psiq 1999; 21:19-28.
31. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Survey (NHANES III). J Clin Endocrinol Metab 20 02; 2: 488-499.